Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis.
Level 2 - randomized trial
Meta-analysis of Mendelian randomization (instrumental variable) observational studies with dramatic, consistent effect size across 312,321 participants.
PubMed 23083789 · doi:10.1016/j.jacc.2012.09.017
What was done
Authors conducted meta-analyses of Mendelian randomization studies to estimate the effect of long-term exposure to lower plasma LDL cholesterol (LDL-C) on coronary heart disease (CHD) risk. They analyzed 9 polymorphisms across 6 genes in non-overlapping cohorts totaling 312,321 participants, and compared the resulting effect per unit of LDL-C reduction with clinical trial data from statin therapy initiated later in life.
What was found
All 9 genetic polymorphisms showed consistent reductions in CHD risk per unit lower LDL-C with no heterogeneity (I² = 0.0%). Naturally randomized long-term exposure to lower LDL-C was associated with a 54.5% reduction in CHD risk per 1 mmol/L (38.7 mg/dL) lower LDL-C (95% CI: 48.8% to 59.5%). This represented a 3-fold greater CHD risk reduction per unit lower LDL-C than observed with statins started later in life (p = 8.43 × 10⁻¹⁹).
Why it matters
This study demonstrates that the clinical benefit of lower LDL-C is cumulative over time, suggesting that maintaining low LDL-C beginning early in life provides substantially greater protection against CHD than starting lipid lowering later in adulthood.
Limits
Mendelian randomization estimates reflect lifelong, continuous genetic exposure and do not directly test the clinical feasibility, timing, or safety of initiating pharmacological interventions early in life. The abstract does not report participant demographics, ancestry breakdown, or specific cohort sources.
Cited by
- supports Mendelian randomization studies demonstrate a direct linear relationship between lifetime exposure to LDL cholesterol and the risk of heart disease.